Impact Factor
4.37
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
7.79
1,582 total citations
h5-index
49
h5 depth signal
Cited share
92.9%
195 of 210
Total citations
1,582
Citation footprint
Metric signal
8.10
External metric anchor
Self-citation
1.4%
22 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
319
Italy
109
United Kingdom
105
China
92
Spain
70
Citing Fields of Research
Protein Structure & Folding
182
Cancer Drugs
155
AI & Machine Learning
120
Oncology
89
Pharmacology & Toxicology
78
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,221
Articles tracked across the journal lifetime
Indexed publication set
210
195 cited publications
Last 12 months
108
9.0 publications/month
Open access share
20.4%
22 OA publications in the last year
Leading citing country
United States
319 citing publications
Leading citing field
Protein Structure & Folding
182 citing publications
Latest tracked publication
15 October 2026
10 recent records available
Coverage & Indexing History
v7n1, Jan. 2012-
v7n1, Jan. 2012- ; selected citations only before this date
Research Focus & Classification
Indexed Subjects
Protein Structure & Folding
AI & Machine Learning
Neurodegenerative Disorders
Antibiotic & Antibacterial Agents
Cancer Drugs
Medical Ethics
Broad Categories
Chemistry Techniques, Analytical
Pharmacology
Protein Structure & Folding
MeSH Descriptors
Drug Design
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1080/17460441.2026.2749519
Open DOI
Targeting fibroimmune remodeling in androgenetic alopecia: emerging opportunities for RNA-based drug discovery
Current treatments for androgenetic alopecia (AGA) primarily suppress androgen signaling or stimulate hair growth. Recent single-cell and spatial transcriptomic studies identify fibroimmune remodeling as a potential source of new AGA tar...
02
DOI 10.1080/17460441.2026.2746971
Open DOI
Current applications of isothermal titration calorimetry for lead optimization
Isothermal titration calorimetry (ITC) is a valuate technique for drug lead optimization by providing a complete thermodynamic profile of ligand-target interactions. ITC further provides mechanistic insights into binding by distinguishin...
03
DOI 10.1080/17460441.2026.2744345
Open DOI
From stochastic systems to governed intelligence: a neurosymbolic path for pharma
Artificial intelligence is being deployed across the pharmaceutical value chain, yet returns have been inconsistent. One of the explanations for this inconsistency is the organizational focus on models rather than the data foundations ne...
04
DOI 10.1080/17460441.2026.2743766
Open DOI
Rethinking zebrafish anxiety models in drug discovery and precision psychiatry
1. Mental health disorders are a leading cause of disability and productivity loss worldwide and continue to have a profound impact on quality of life and mortality. They are considered a clinicall...
05
DOI 10.1080/17460441.2026.2742992
Open DOI
Organoids in drug discovery and development: emerging technologies to transition beyond animal models
1. Growing practical and ethical concerns regarding the use of animals for disease modeling and drug testing are motivating improvements to the current drug development process. Drug development ta...
06
DOI 10.1080/17460441.2026.2742988
Open DOI
Using molecular modeling and QSAR-based design strategies for advancing the development of therapeutic solute carrier 6 (SLC6) transporter ligands
1. The solute carrier 6 (SLC6) transporter family belongs to the SLC superfamily and includes sodium-dependent secondary active cotransporters that utilize sodium gradients to drive the translocati...
07
DOI 10.1080/17460441.2026.2739391
Open DOI
Lymph node models of chronic lymphocytic leukemia for translational evaluation of new drug candidates
08
DOI 10.1080/17460441.2026.2736532
Open DOI
Strategy-based design for the identification of next generation β-lactam antibiotics that evade resistance from Gram-negative pathogens
β-Lactam antibiotics have defined antibacterial chemotherapy for over eight decades and remain indispensable for the treatment of bacterial infections. Despite their clinical success, escalating antimicrobial resistance, particularly amo...
09
DOI 10.1080/17460441.2026.2737326
Open DOI
Design considerations for in silico drug discovery platform that can accelerate targeted drug repurposing: a focus on rare, neglected, and emerging diseases
1. The pharmaceutical industry has experienced a sustained decline in R&D productivity over the past several decades. Multiple factors have been proposed to explain this trend, including increasing...
10
DOI 10.1080/17460441.2026.2736534
Open DOI
The rapid emergence of small molecule RNA modulator hit discovery: unlocking the potential
1. RNA has long been considered as a fundamental intermediary between DNA and protein. However, our understanding of its biological role has expanded considerably over the past two decades, present...
Bibliographical & Catalog Notes
Description based on: Vol. 1, no. 7 (Dec. 2006); title from cover.
Also issued online.